NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company

SHELTON, CT / ACCESS Newswire / March 11, 2025 / NanoViricides, Inc. (the "Company")(NYSE American:NNVC), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that the viruses cannot escape, declared today that its business is not affected by the tariff policies of the US government or corresponding retaliatory policies of other governments, nor is it affected by the spending cuts being implemented by the current White House administration.

Therefore, the Company believes that smart financial strategists would view the longer term strong prospects of the Company (explained below) as supporting the case of NNVC as an effective hedge against the current general stock market turmoil.

Additionally, the Company reports that it does not develop vaccines. On the contrary, the Company is developing antiviral treatments, that are for helping patients infected by viruses.

"We believe that the policies of the current Secretary of HHS, Mr. Robert F. Kennedy, would lead to focusing more strongly on development of broad-spectrum antiviral treatments such as our clinical-stage as well as earlier-stage antiviral pipeline drug products rather than the previous vaccine-focused strategy," said Anil R. Diwan, PhD, President and Executive Chairman of the Company.

The Company has recently suggested that its revolutionary broad-spectrum antiviral drug NV-387 could have strong potential for the treatment of measles.

NV-387 was found to cure a lethal RSV infection in an animal model. Both Measles virus and RSV belong to the same family of viruses called paramyxoviruses. This family of viruses use heparan sulfated proteoglycans as their first stop, congregating next to cells, before gaining entry into cells.

There is no treatment available for measles; the lack of treatment is fueling the spread of this highly contagious disease.

Only a treatment for measles can effectively limit transmission of the virus and spread of the contagion, the Company believes.

It is illogical and unscientific to believe that vaccination, which is being widely promoted, would have any immediate effect for controlling the current outbreak. This is because the vaccinated person will only become protected several weeks after receiving the vaccine dose. Additionally, immune-compromised subjects cannot be vaccinated.

Although measles is spreading primarily in unvaccinated children, a small proportion of vaccinated persons is also being infected, and could suggest a drift in the virus towards partial vaccine escape. The rapid spread of measles in West Texas is bleeding into nearby areas due to travel. Several other states have reported independently initiated measles cases as well. So far there were two deaths with measles.